Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 15130793)

Published in Appl Bioinformatics on January 01, 2003

Authors

Jennifer Listgarten1, Kathryn Graham, Sambasivarao Damaraju, Carol Cass, John Mackey, Brent Zanke

Author Affiliations

1: PolyomX Program, Cross Cancer Institute, University of Alberta, Alberta Cancer Board, Edmonton, AB, Canada. jenn@cs.toronto.ca

Articles by these authors

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med (2011) 12.52

The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91

Adjuvant docetaxel for node-positive breast cancer. N Engl J Med (2005) 8.00

The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction (2010) 5.14

The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction (2003) 4.92

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol (2009) 4.66

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog (2009) 4.24

Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. Lancet Oncol (2013) 3.67

Alcohol as a risk factor for global burden of disease. Eur Addict Res (2003) 3.11

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology (2013) 3.01

Germ-line DNA copy number variation frequencies in a large North American population. Hum Genet (2007) 2.94

PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res (2008) 2.63

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer (2003) 2.52

Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev (2010) 2.35

Drinking patterns, drinking contexts and alcohol-related aggression among late adolescent and young adult drinkers. Addiction (2005) 2.27

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res (2004) 2.06

Policy implications of the widespread practice of 'pre-drinking' or 'pre-gaming' before going to public drinking establishments: are current prevention strategies backfiring? Addiction (2009) 2.01

Measuring alcohol consumption--should the 'graduated frequency' approach become the norm in survey research? Addiction (2006) 1.89

Intimate partner violence victimization and alcohol consumption in women: a systematic review and meta-analysis. Addiction (2013) 1.85

Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology (2010) 1.81

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene (2003) 1.73

Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology (2012) 1.67

DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat (2010) 1.65

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther (2005) 1.50

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. J Pathol (2013) 1.47

Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories. Clin Breast Cancer (2004) 1.46

Aggression involving alcohol: relationship to drinking patterns and social context. Addiction (2003) 1.41

Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev (2011) 1.40

Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res (2002) 1.37

Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res (2004) 1.33

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients. Clin Cancer Res (2012) 1.27

Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10. Clin Cancer Res (2007) 1.26

Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg (2006) 1.20

Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr (2011) 1.20

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract (2005) 1.16

Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med (2011) 1.15

The role of human nucleoside transporters in uptake of 3'-deoxy-3'-fluorothymidine. Mol Pharmacol (2008) 1.14

Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr Top Med Chem (2011) 1.14

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. Clin Cancer Res (2004) 1.12

The importance of environmental modifiers of the relationship between substance use and harm. Addiction (2004) 1.10

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer. Lung Cancer (2005) 1.09

Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum Genet (2011) 1.08

STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer. Int J Clin Exp Pathol (2010) 1.07

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer. Lancet Oncol (2005) 1.06

Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer. Breast (2007) 1.06

Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One (2010) 1.05

When do first-year college students drink most during the academic year? An internet-based study of daily and weekly drinking. J Am Coll Health (2010) 1.05

Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res (2002) 1.04

Drinking and its burden in a global perspective: policy considerations and options. Eur Addict Res (2003) 1.04

Social inequalities and gender differences in the experience of alcohol-related problems. Alcohol Alcohol (2012) 1.04

Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am J Pathol (2011) 1.03

Where, with whom, and how much alcohol is consumed on drinking events involving aggression? Event-level associations in a Canadian national survey of university students. Alcohol Clin Exp Res (2008) 1.03

Drinking before going to licensed premises: an event-level analysis of predrinking, alcohol consumption, and adverse outcomes. Alcohol Clin Exp Res (2012) 1.03

"Every male in there is your competition": young men's perceptions regarding the role of the drinking setting in male-to-male barroom aggression. Subst Use Misuse (2009) 1.02

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. J Cell Physiol (2010) 1.02

Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role. Psychooncology (2010) 1.01

Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model. J Nucl Med (2010) 1.00

Gender differences in the relationship between heavy episodic drinking, social roles, and alcohol-related aggression in a U.S. sample of late adolescent and young adult drinkers. Am J Drug Alcohol Abuse (2007) 1.00

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol (2003) 1.00

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. Neuro Oncol (2010) 0.99

Is the smoking-depression relationship confounded by alcohol consumption? An analysis by gender. Nicotine Tob Res (2008) 0.98

The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells. Int J Cancer (2011) 0.96

Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One (2013) 0.96

Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC). Curr Cancer Drug Targets (2011) 0.94

Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical study. Hum Pathol (2010) 0.93

Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer. Int J Breast Cancer (2012) 0.92

Verbal versus physical victimization from other people's drinking: how do gender, age, and their interactions with drinking pattern affect vulnerability? J Stud Alcohol Drugs (2007) 0.91

Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J Pharmacol Exp Ther (2003) 0.90

The influence of status on group drinking by young adults: a survey of natural drinking groups on their way to and from bars. Alcohol Clin Exp Res (2013) 0.90

P-selectin genotype is associated with the development of cancer cachexia. EMBO Mol Med (2012) 0.89

"Why did it happen?" A review and conceptual framework for research on perpetrators' and victims' explanations for intimate partner violence. Aggress Violent Behav (2010) 0.88

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer. PLoS One (2013) 0.88

'I have no interest in drinking': a cross-national comparison of reasons why men and women abstain from alcohol use. Addiction (2009) 0.88

Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet). Biopreserv Biobank (2012) 0.88

Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience. Biopreserv Biobank (2013) 0.88

Defending girlfriends, buddies and oneself: injunctive norms and male barroom aggression. Addict Behav (2010) 0.87

Third party involvement in barroom conflicts. Aggress Behav (2013) 0.87

Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane. Am J Clin Oncol (2007) 0.87

Not just the booze talking: trait aggression and hypermasculinity distinguish perpetrators from victims of male barroom aggression. Alcohol Clin Exp Res (2010) 0.87

Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia. PLoS One (2012) 0.86

Associations of hair cortisol concentration with self-reported measures of stress and mental health-related factors in a pooled database of diverse community samples. Stress (2014) 0.85

First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II. Radiother Oncol (2010) 0.85

Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence. PLoS One (2013) 0.85

Do predisposing and family background characteristics modify or confound the relationship between drinking frequency and alcohol-related aggression? A study of late adolescent and young adult drinkers. Addict Behav (2005) 0.85

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. Clin Breast Cancer (2002) 0.84

A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility. Eur J Hum Genet (2012) 0.84

Do individual and situational factors explain the link between predrinking and heavier alcohol consumption? An event-level study of types of beverage consumed and social context. Alcohol Alcohol (2014) 0.84